AAPL   393.67 (+2.60%)
FB   248.20 (+1.28%)
GOOGL   1,549.40 (+0.68%)
NVDA   429.69 (+2.51%)
CGC   17.57 (+0.86%)
BABA   262.32 (+0.50%)
TSLA   1,718.48 (+11.25%)
AMD   57.68 (+3.22%)
GILD   76.83 (+0.67%)
DIS   118.75 (-0.49%)
NFLX   573.28 (+4.47%)
AAPL   393.67 (+2.60%)
FB   248.20 (+1.28%)
GOOGL   1,549.40 (+0.68%)
NVDA   429.69 (+2.51%)
CGC   17.57 (+0.86%)
BABA   262.32 (+0.50%)
TSLA   1,718.48 (+11.25%)
AMD   57.68 (+3.22%)
GILD   76.83 (+0.67%)
DIS   118.75 (-0.49%)
NFLX   573.28 (+4.47%)
AAPL   393.67 (+2.60%)
FB   248.20 (+1.28%)
GOOGL   1,549.40 (+0.68%)
NVDA   429.69 (+2.51%)
CGC   17.57 (+0.86%)
BABA   262.32 (+0.50%)
TSLA   1,718.48 (+11.25%)
AMD   57.68 (+3.22%)
GILD   76.83 (+0.67%)
DIS   118.75 (-0.49%)
NFLX   573.28 (+4.47%)
AAPL   393.67 (+2.60%)
FB   248.20 (+1.28%)
GOOGL   1,549.40 (+0.68%)
NVDA   429.69 (+2.51%)
CGC   17.57 (+0.86%)
BABA   262.32 (+0.50%)
TSLA   1,718.48 (+11.25%)
AMD   57.68 (+3.22%)
GILD   76.83 (+0.67%)
DIS   118.75 (-0.49%)
NFLX   573.28 (+4.47%)
Log in

NYSEAMERICAN:CPHIChina Pharma Stock Price, Forecast & News

$0.56
+0.02 (+3.50 %)
(As of 07/13/2020 10:02 AM ET)
Add
Compare
Today's Range
$0.53
Now: $0.56
$0.56
50-Day Range N/A
52-Week Range
$0.21
Now: $0.56
$1.40
Volume1,191 shs
Average Volume2.94 million shs
Market Capitalization$24.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.68 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CPHI
Previous SymbolNYSEMKT:CPHI
CUSIPN/A
CIKN/A
Phone8689866811730

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees240
Market Cap$24.36 million
Next Earnings Date8/20/2020 (Estimated)
OptionableNot Optionable

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions

When is China Pharma's next earnings date?

China Pharma is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for China Pharma.

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) posted its earnings results on Friday, May, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company earned $1.76 million during the quarter. View China Pharma's earnings history.

Has China Pharma been receiving favorable news coverage?

Media headlines about CPHI stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. China Pharma earned a media sentiment score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about China Pharma.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 253,900 shares, an increase of 102.1% from the June 15th total of 125,600 shares. Based on an average trading volume of 1,830,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.2% of the shares of the company are short sold. View China Pharma's Current Options Chain.

Who are some of China Pharma's key competitors?

What other stocks do shareholders of China Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include Inovio Pharmaceuticals (INO), NovaBay Pharmaceuticals (NBY), Novavax (NVAX), AbbVie (ABBV), Ibio (IBIO), Agile Therapeutics (AGRX), Biocept (BIOC), Biopharmx (BPMX), Gilead Sciences (GILD) and Micron Technology (MU).

Who are China Pharma's key executives?

China Pharma's management team includes the following people:
  • Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (Age 66)

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.56.

How big of a company is China Pharma?

China Pharma has a market capitalization of $24.36 million. China Pharma employs 240 workers across the globe.

What is China Pharma's official website?

The official website for China Pharma is www.chinapharmaholdings.com.

How can I contact China Pharma?

China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at 8689866811730.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.